Increased Oxidative Stress in Experimental Renovascular Hypertension

作者: Lilach O. Lerman , Karl A. Nath , Martin Rodriguez-Porcel , James D. Krier , Robert S. Schwartz

DOI: 10.1161/01.HYP.37.2.541

关键词:

摘要: The pathophysiological mechanisms responsible for maintenance of chronic renovascular hypertension remain undefined. Excess angiotensin II generation may lead to release reactive oxygen species and increased vasoconstrictor activity. To examine the potential involvement oxidation-sensitive in pathophysiology hypertension, blood samples were collected renal flow measured with electron-beam computed tomography pigs 5 10 weeks after induction unilateral artery stenosis (n=7) or sham operation (n=7). Five procedure, plasma renin activity mean arterial pressure elevated hypertensive pigs. Levels prostaglandin F2α (PGF 2α )–isoprostanes, vasoconstrictors markers oxidative stress, also significantly (157±21 versus 99±16 pg/mL; P r =0.83) ( =0.82). By weeks, returned baseline but remained (144±10 115±5 mm Hg; =0.7) not Stenotic kidney was decreased at both studies. In shock-frozen cortical tissue, ex vivo endogenous intracellular radical scavengers kidneys. present study demonstrates, first time, that early an increase is associated systemic stress. When later declines, PGF -isoprostanes elevated, possibly due local activation slow responses II, participate sustenance pressure. Moreover, influence ischemic parenchymal injury.

参考文章(33)
A. Lewis Farr, Oliver H. Lowry, Rose J. Randall, Nira J. Rosebrough, Protein Measurement with the Folin Phenol Reagent Journal of Biological Chemistry. ,vol. 193, pp. 265- 275 ,(1951)
Zhongzhen Nie, Yun Mei, Mary Ford, Leonard Rybak, Adrianna Marcuzzi, Hongzu Ren, Gary L. Stiles, Vickram Ramkumar, Oxidative stress increases A1 adenosine receptor expression by activating nuclear factor kappa B. Molecular Pharmacology. ,vol. 53, pp. 663- 669 ,(1998) , 10.1124/MOL.53.4.663
J. D. Morrow, K. E. Hill, R. F. Burk, T. M. Nammour, K. F. Badr, L. J. Roberts, A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 87, pp. 9383- 9387 ,(1990) , 10.1073/PNAS.87.23.9383
S Rajagopalan, S Kurz, T Münzel, M Tarpey, B A Freeman, K K Griendling, D G Harrison, Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. Journal of Clinical Investigation. ,vol. 97, pp. 1916- 1923 ,(1996) , 10.1172/JCI118623
A. M. Von Thun, S. S. el-Dahr, R. C. Vari, L. G. Navar, Modulation of renin-angiotensin and kallikrein gene expression in experimental hypertension. Hypertension. ,vol. 23, pp. 131- 136 ,(1994) , 10.1161/01.HYP.23.1_SUPPL.I131
Edgar A. Jaimes, Josep Maria Galceran, Leopoldo Raij, Angiotensin II induces superoxide anion production by mesangial cells Kidney International. ,vol. 54, pp. 775- 784 ,(1998) , 10.1046/J.1523-1755.1998.00068.X
Claudio Napoli, Joseph L. Witztum, Filomena de Nigris, Giuseppe Palumbo, Francesco P. D’Armiento, Wulf Palinski, Intracranial Arteries of Human Fetuses Are More Resistant to Hypercholesterolemia-Induced Fatty Streak Formation Than Extracranial Arteries Circulation. ,vol. 99, pp. 2003- 2010 ,(1999) , 10.1161/01.CIR.99.15.2003
L. JACKSON ROBERTS, JASON D. MORROW, Isoprostanes. Novel markers of endogenous lipid peroxidation and potential mediators of oxidant injury. Annals of the New York Academy of Sciences. ,vol. 744, pp. 237- 242 ,(1994) , 10.1111/J.1749-6632.1994.TB52741.X
Mustafa Kavutcu, Orhan Canbolat, Serdar Öztürk, Ekmel Olcay, Satilmis Ulutepe, Cemil Ekinci, Ismail Hakki Gökhun, Ilker Durak, Reduced Enzymatic Antioxidant Defense Mechanism in Kidney Tissues from Gentamicin-Treated Guinea Pigs: Effects of Vitamins E and C Nephron. ,vol. 72, pp. 269- 274 ,(1996) , 10.1159/000188853
Helgi J. Oskarsson, Donald D. Heistad, Oxidative Stress Produced by Angiotensin Too Implications for Hypertension and Vascular Injury Circulation. ,vol. 95, pp. 557- 559 ,(1997) , 10.1161/01.CIR.95.3.557